Safety Considerations and Contraindications Who Should Avoid BPC-157 Contraindications : Active cancer diagnosis (due to angiogenic properties) Pregnancy or breastfeeding Severe cardiovascular disease Known hypersensitivity to peptides Drug Interactions BPC-157 has minimal known drug interactions but may potentially interact with: Anticoagulant medications (enhanced healing may affect clotting) Immunosuppressive drugs Other growth factors or healing peptides Medical Supervision Requirements Consult healthcare providers before starting BPC-157 if you have: Chronic medical conditions Recent surgical procedures Blood clotting disorders Current prescription medications Our Clinics Experience with BPC-157 Dosing Through extensive clinical experience with BPC-157 protocols, weve observed optimal healing results with 300 mcg daily split dosing for most applications
Detection Limit of 0.4 U/L
Heart Attack: Resulting from reduced blood flow to the heart muscle
Glutathione therapy gives your body a direct boost of this essential antioxidant, helping to fight off free radicals that cause aging and cell damage
Young reports grants and personal fees from Allergan, grants and personal fees from Amgen, personal fees from Avanir, grants and personal fees from Alder (now Lundbeck), personal fees from Cipla, grants and personal fees from Eli Lilly, personal fees from Supernus, grants from Autonomic Technologies, grants from Colucid, grants from Cumberland, grants from Dr
